Nope, there wasn't any news, but they have a priority review PDUFA date for a drug the FDA may/may not approve in April. It's moving strong so I wonder if someone, somewhere knows something everyone else doesn't.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.